NCT03058744

Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis

A Phase 1b Open Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics and HPA Axis Suppression Potential of Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 94 (actual)
• Sponsor: Bausch Health Americas, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Suppression Potential of Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects with Moderate to Severe Plaque Psoriasis.

Detailed description

A Phase 1b Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics and HPA Axis Suppression Potential of Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects with Moderate to Severe Plaque Psoriasis.

Conditions

• Psoriasis

Interventions

Type	Name	Description
DRUG	IDP-118 Lotion	Lotion
DRUG	HP Monad Lotion	Lotion
DRUG	Ultravate Cream	Cream
DRUG	Tazorac Cream	Cream

Timeline

• Start date: 2015-04-01
• Primary completion: 2016-12-01
• Completion: 2017-01-01
• First posted: 2017-02-23
• Last updated: 2017-06-09

Locations

12 sites across 1 country: United States